Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
National Taiwan University Hospital · Massachusetts General Hospital · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
979
total citations
- FWCI
- 54.87
- Percentile
- 100%
- References
- 30
Citations per year
Authors
13Topics & keywords
Topics
Keywords
- Afatinib
- Lung
- Medicine
- Lung cancer
- Internal medicine
- Pathology
- Oncology
- Erlotinib
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.